Human health risk assessment of chloroxylenol in liquid hand soap and dishwashing soap used by consumers and health-care professionals

https://doi.org/10.1016/j.yrtph.2016.06.003Get rights and content

Highlights

  • Human risk assessment of chloroxylenol in liquid hand and dishwashing soap products.

  • Consumers and health-care workers considered in health protective scenarios.

  • Minimal systemic toxicity and no evidence of genotoxicity, or carcinogenicity.

  • Estimates likely overestimate exposure and risk (e.g. 100% dermal penetration).

  • Resulting MOEs 178 to >100,000,000 indicate negligibly small potential for harm.

Abstract

A quantitative human risk assessment of chloroxylenol was conducted for liquid hand and dishwashing soap products used by consumers and health-care workers. The toxicological data for chloroxylenol indicate lack of genotoxicity, no evidence of carcinogenicity, and minimal systemic toxicity. No observed adverse effect levels (NOAEL) were established from chronic toxicity studies, specifically a carcinogenicity study that found no cancer excess (18 mg/kg-day) and studies of developmental and reproductive toxicity (100 mg/kg-day). Exposure to chloroxylenol for adults and children was estimated for two types of rinse-off cleaning products, one liquid hand soap, and two dishwashing products. The identified NOAELs were used together with exposure estimates to derive margin of exposure (MOE) estimates for chloroxylenol (i.e., estimates of exposure over NOAELs). These estimates were designed with conservative assumptions and likely overestimate exposure and risk (i.e., highest frequency, 100% dermal penetration). The resulting MOEs ranged from 178 to over 100, 000, 000 indicating negligibly small potential for harm related to consumer or health-care worker exposure to chloroxylenol in liquid soaps used in dish washing and hand washing.

Section snippets

Background

Chloroxylenol (4-chloro-3, 5-dimethylphenol or PCMX; CAS No. 88-04-0, see Fig. 1) is an antimicrobial chemical with a long history of safe use in topical antiseptic drug products for over-the-counter human use (FDA, 2013, FDA, 1994), and for pesticide use (EPA, 1994, EPA, 2009a, EPA, 2009b). A human health risk assessment was conducted to evaluate the safety of chloroxylenol used as an active ingredient in rinse-off liquid antimicrobial hand soaps and dish soaps by consumer (adults and

Methods

This quantitative human health risk assessment includes (1) a hazard assessment to determine whether toxicity data for chloroxylenol are sufficient and derivation of no observed adverse effect levels (NOAELs), (2) an exposure assessment for consumer and health-care uses of liquid soaps containing chloroxylenol, and (3) calculation of the margin of exposure (MOE) for different product use scenarios, i.e., the ratio of the experimental NOAEL to the estimated human exposure level for each of the

Hazard assessment

A hazard assessment was conducted for chloroxylenol to evaluate all available toxicology data and consider the studies that could be used to establish a no observed adverse effect level (NOAEL) for chloroxylenol. Relevant reviews providing data on toxicity of chloroxylenol include the following: the Environmental Protection Agency (EPA) hazard and exposure evaluations for pesticide use (EPA, 1994, EPA, 2009a), the FDA (2013) analysis and request for data, a “white paper” risk assessment

Acute toxicity studies

Available acute exposure studies, lethality or LD50 studies, indicate low acute toxicity of chloroxylenol and provide some useful information on organ systems affected at such lethal doses. A summary of the LD50 and lethality data was completed in 1986 by Guess and Bruch, and similar summaries appear in the Handbook of Disinfectants and Antiseptics (Bruch, 1996) and the EPA Reregistration Eligibility Decision (RED) for chloroxylenol (EPA, 1994) (Table 1).

As presented in Table 1, LD50 values

Selection of NOAELS for margin of exposure analysis

While limitations exist in the toxicological database for chloroxylenol, the existing dataset indicate lack of genotoxicity and carcinogenicity and low acute, systemic and DART toxicity. Overall the existing toxicity data are sufficient for conducting a quantitative risk assessment for consumer and health-care worker exposure to chloroxylenol in hand or dish soap. The data used include the NOAEL of 100 mg/kg-day for maternal toxicity identified in the study by Siglin (1991) supported by the

Exposure assessment and margin of exposure (MOE) estimates

Procedures described by Sanderson et al. (2006), which use algorithms, and methods identified by USEPA., 1989, EPA, 2011 together with inputs from the EPA Exposure Factors Handbook (EPA, 2011) were used to estimate exposure to chloroxylenol resulting from three exposure scenarios: one related to the use of antimicrobial hand soap and two related to the use of dish washing with products containing chloroxylenol. In each case, “high” and “low” exposure scenarios are considered that differ in the

Discussion

Chloroxylenol has a long history of safe use in topical antiseptic drug products for over-the-counter human use and in hard surface disinfectant use (regulated as a pesticide). This human health risk assessment was conducted to evaluate the adequacy of existing toxicological data and to evaluate human risk for consumer and health-care worker use of rinsed off hand soap and dish soap in response to concerns raised within the FDA Proposed Rules on topical antimicrobial drug products for OTC human

Conclusions

The existing toxicity data for chloroxylenol have limitations, but taken together the data are adequate for evaluation of the risks associated with consumer and health-care exposure to chloroxylenol in hand soap or dish soap. The NOAEL of 100 mg/kg-day for maternal toxicity from Siglin (1991) supported by Noda et al. (1983) to address DART and a NOAEL of 18 mg/kg-day for chronic systemic exposure from Momma et al. (1988) represent a health-protective means to evaluate risks for this use.

Acknowledgements

The authors gratefully acknowledge funding for this work provided by the American Cleaning Institute.

References (42)

  • G. Klopman et al.

    Screening of high production volume chemicals for estrogen receptor binding activity (II) by the MultiCASE expert system

    Chemosphere

    (2003)
  • A. Nakama et al.

    Evaluation of estrogenic activity of organic biocides using ER-binding and YES assay

    Food Chem. Toxicol.

    (2007)
  • AISE HERA Habits and practices (Developed by AISE within HERA project in 2002). Data not reviewed here as described in...
  • American Cleaning Institute

    Consumer Product Ingredient Safety: Exposure and Risk Screening Methods for Consumer Product Ingredients

    (2010)
  • M.K. Bruch

    Chloroxylenol: an old-new antimicrobial

  • H. Chesterman et al.

    RBA 666. Oral Toxicity Studies in Beagle Dogs. Initial Studies

    (1973)
  • H. Chesterman et al.

    RBA 666. Oral Toxicity Studies in Beagle Dogs. Repeat Dosage for 13 Weeks

    (1973)
  • R.E. Davies et al.

    Effects of Repeated Applications of Dettol RBA 666 to the Vaginal Mucosa of Rabbits for Two Weeks

    (1974)
  • A. Dorantes et al.

    Pharmacokinetic and metabolic disposition of p-chloro-mxylenol (PCMX) in dogs

    Pharm. Res.

    (1992)
  • R.L. Doyle et al.

    Acute Eye Application of Ottasept Extra to Albino Rabbits: P-12B

    (1965)
  • Envirosystems. Undated. Chloroxylenol toxicology. Available at http://envirosi.com/chloroxylenol-toxicology/. Accessed...
  • U. S. Environmental Protection Agency (EPA)

    Reregistration Eligibility Decision (RED)

    (1994)
  • U. S. Environmental Protection Agency (EPA)

    Summary of Human Health Effects Data for the Chloroxylenol Registration Review Decision Document

    (2009)
  • U. S. Environmental Protection Agency (EPA)

    Chloroxylenol Summary Document: Registration Review Preliminary Work Plan

    (2009)
  • U. S. Environmental Protection Agency (EPA)

    Exposure Factors Handbook 2011 EPA/600/R-09/052F September 2011

    (2011)
  • European Union

    Regulation (EU) No. 528/2012 of the European Parliament and of the Council of 22 May 2012 Concerning the Making Available on the Market and Use of Biocidal Products

    (2014)
  • Exponent

    FDA Consumer Antiseptics Rule: FDA Request for Data on Safety and Efficacy of Chloroxylenol

    (2014)
  • Food and Drug Administration (FDA)

    S tentative final monograph for healthcare antiseptic drug products

    Fed. Regist.

    (1994)
  • Food and Drug Administration (FDA)

    . Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-counter Human Use; Proposed Amendment of the Tentative Final Monograph; Reopening the Administrative Record

    (2013)
  • Food and Drug Administration (FDA)

    Briefing Document for a Meeting of the Nonprescription Drugs Advisory Committee

    (2014)
  • S. Georgieva et al.

    Metabolic estrogenic activity of some endocrine disruptorchemicals

    Pharmacia

    (2011)
  • Cited by (24)

    • Exploring the impact of daily food habit and modification of lifestyle for boosting immunity against COVID-19

      2022, Heliyon
      Citation Excerpt :

      Data depicts that out of 146 respondents, 4.35% and 2.48% of respondents clean foods by using detergent or soap and using bleaching powder. However, it has been reported that cleaning food with any soap is harmful to health [33]. Additionally, precaution should be taken during washing foods because cross contaminations can occur [34] that can be a double threat to health in this pandemic situation [35, 36].

    View all citing articles on Scopus
    View full text